By Doug Macron

Tekmira Pharmaceuticals this week scored a victory in its technology-misappropriation lawsuit against Alnylam Pharmaceuticals and AlCana Technologies, announcing that a British Columbia court has granted its request for an injunction ordering AlCana to return confidential documents and materials to Tekmira in advance of a trial.

The injunction also orders AlCana to disclose “every person and corporation to whom the information was provided or communicated,” Tekmira said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.